OPA1, Mfn1, Mfn2, and PGC-1 α expression decreased in the PCOS group compared to the control group (p < 0.05), but increased after administration of CFDT decoction and metformin (p < 0.05). This evidence concerns the gene MFN2 and polycystic ovary syndrome.